摘要 |
Compounds of Formula 1 and pharmaceutically acceptable salts thereof, wherein m, Ar, R<SUP>1</SUP>, R<SUP>2</SUP>, and R<SUP>3 </SUP>are as defined herein. The invention also provides methods for preparing, coompositions comprising, and methods for using compounds of Formula 1 for treatment of central nervous system disorders.
|